Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a protocol for a systematic review and network meta-analysis of primary prevention trials
- PMID: 25875487
- PMCID: PMC4379718
- DOI: 10.1186/s13643-015-0029-z
Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a protocol for a systematic review and network meta-analysis of primary prevention trials
Abstract
Background: In the Western world, dietary supplements are commonly used to prevent chronic diseases, mainly cardiovascular disease and cancer. However, there is inconsistent evidence on which dietary supplements actually lower risk of chronic disease, and some may even increase risk. We aim to evaluate the comparative safety and/or effectiveness of dietary supplements for the prevention of mortality (all-cause, cardiovascular, and cancer) and cardiovascular and cancer incidence in primary prevention trials.
Methods/design: We will search PubMed, EMBASE, Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects, the Cochrane Central Register of Controlled Trials, clinical trials.gov, and the World Health Organization International Trial Registry Platform. Randomized controlled trials will be included if they meet the following criteria: (1) minimum intervention period of 12 months; (2) primary prevention of chronic disease (is concerned with preventing the onset of diseases and conditions); (3) minimum mean age ≥18 years (maximum mean age 70 years); (4) intervention(s) include vitamins (beta-carotene, vitamin A, B vitamins, Vitamin C, Vitamin D, Vitamin E, and multivitamin supplements); fatty acids (omega-3 fatty acids, omega-6 fatty acids, monounsaturated fat); minerals (magnesium, calcium, selenium, potassium, iron, zinc, copper, iodine; multiminerals); supplements containing combinations of both vitamins and minerals; protein (amino acids); fiber; prebiotics; probiotics; synbiotics; (5) supplements are orally administered as liquids, pills, capsules, tablets, drops, ampoules, or powder; (6) report results on all-cause mortality (primary outcome) and/or mortality from cardiovascular disease or cancer, cardiovascular and/or cancer incidence (secondary outcomes). Pooled effects across studies will be calculated using Bayesian random effects network meta-analysis. Sensitivity analysis will be performed for trials lasting ≥5 years, trials with low risk of bias, trials in elderly people (≥65 years), ethnicity, geographical region, and trials in men and women. The results of the corresponding fixed effects models will also be compared in sensitivity analyses.
Discussion: This is a presentation of the study protocol only. Results and conclusions are pending completion of this study. Our systematic review will be of great value to consumers of supplements, healthcare providers, and policy-makers, regarding the use of dietary supplements.
Prospero: CRD42014014801 .
Similar articles
-
The effects of prenatal dietary supplements on blood glucose and lipid metabolism in gestational diabetes mellitus patients: A systematic review and network meta-analysis protocol of randomized controlled trials.PLoS One. 2022 May 3;17(5):e0267854. doi: 10.1371/journal.pone.0267854. eCollection 2022. PLoS One. 2022. PMID: 35503790 Free PMC article.
-
Micronutrient supplementation in adults with HIV infection.Cochrane Database Syst Rev. 2017 May 18;5(5):CD003650. doi: 10.1002/14651858.CD003650.pub4. Cochrane Database Syst Rev. 2017. PMID: 28518221 Free PMC article. Review.
-
Dietary Supplements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis of Primary Prevention Trials.Adv Nutr. 2017 Jan 17;8(1):27-39. doi: 10.3945/an.116.013516. Print 2017 Jan. Adv Nutr. 2017. PMID: 28096125 Free PMC article. Review.
-
Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task Force.Ann Intern Med. 2013 Dec 17;159(12):824-34. doi: 10.7326/0003-4819-159-12-201312170-00729. Ann Intern Med. 2013. PMID: 24217421 Review.
-
Drugs for preventing lung cancer in healthy people.Cochrane Database Syst Rev. 2012 Oct 17;10:CD002141. doi: 10.1002/14651858.CD002141.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Mar 4;3:CD002141. doi: 10.1002/14651858.CD002141.pub3. PMID: 23076895 Updated. Review.
Cited by
-
The association of the Affordable Care Act with nutrient consumption in adults in the United States.Front Public Health. 2023 Dec 22;11:1244042. doi: 10.3389/fpubh.2023.1244042. eCollection 2023. Front Public Health. 2023. PMID: 38186698 Free PMC article.
-
Probiotics for glycemic and lipid profile control of the pre-diabetic patients: a randomized, double-blinded, placebo-controlled clinical trial study.Diabetol Metab Syndr. 2023 Apr 10;15(1):71. doi: 10.1186/s13098-023-01050-9. Diabetol Metab Syndr. 2023. PMID: 37038214 Free PMC article.
-
Prevalence of dietary supplement use and knowledge, attitudes, practice (KAP) and associated factors in student population: A cross-sectional study.Heliyon. 2023 Mar 22;9(4):e14736. doi: 10.1016/j.heliyon.2023.e14736. eCollection 2023 Apr. Heliyon. 2023. PMID: 37025895 Free PMC article.
-
The Comparative Effects of Different Types of Oral Vitamin Supplements on Arterial Stiffness: A Network Meta-Analysis.Nutrients. 2022 Feb 27;14(5):1009. doi: 10.3390/nu14051009. Nutrients. 2022. PMID: 35267985 Free PMC article. Review.
-
Drugs for preventing lung cancer in healthy people.Cochrane Database Syst Rev. 2020 Mar 4;3(3):CD002141. doi: 10.1002/14651858.CD002141.pub3. Cochrane Database Syst Rev. 2020. PMID: 32130738 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical